{"id":560805,"date":"2026-07-10T14:14:54","date_gmt":"2026-07-10T12:14:54","guid":{"rendered":"https:\/\/medizinonline.com\/recommandation-de-loms-concernant-le-glp-1-dans-le-traitement-de-lobesite\/"},"modified":"2026-07-10T17:56:43","modified_gmt":"2026-07-10T15:56:43","slug":"recommandation-de-loms-concernant-le-glp-1-dans-le-traitement-de-lobesite","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/recommandation-de-loms-concernant-le-glp-1-dans-le-traitement-de-lobesite\/","title":{"rendered":"Recommandation de l’OMS concernant le GLP-1 dans le traitement de l’ob\u00e9sit\u00e9"},"content":{"rendered":"\n

Avec ces lignes directrices publi\u00e9es le 1er d\u00e9cembre 2025, l\u2019Organisation mondiale de la sant\u00e9 a pr\u00e9sent\u00e9 pour la premi\u00e8re fois une recommandation applicable \u00e0 l\u2019\u00e9chelle mondiale concernant la prise en charge m\u00e9dicamenteuse de l\u2019ob\u00e9sit\u00e9 chez l\u2019adulte. Elles ont \u00e9t\u00e9 publi\u00e9es en m\u00eame temps qu\u2019un article d\u2019accompagnement dans le Journal of the American Medical Association<\/em>. Il s\u2019agit l\u00e0 de bien plus qu\u2019une simple mise \u00e0 jour technique : l\u2019OMS reconna\u00eet ainsi explicitement l\u2019ob\u00e9sit\u00e9 comme une maladie chronique et r\u00e9cidivante qui, \u00e0 l\u2019instar de l\u2019hypertension ou du diab\u00e8te, n\u00e9cessite un traitement structur\u00e9 \u00e0 long terme. Pour les cabinets de m\u00e9decine g\u00e9n\u00e9rale, de diab\u00e9tologie et de cardiologie, la question n\u2019est donc plus de savoir si les traitements \u00e0 base de GLP-1 ont leur place, mais plut\u00f4t \u00e0 qui ils s\u2019adressent, dans quel cadre et avec quelles obligations ils doivent \u00eatre utilis\u00e9s. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Avec ces lignes directrices publi\u00e9es le 1er d\u00e9cembre 2025, l\u2019Organisation mondiale de la sant\u00e9 a pr\u00e9sent\u00e9 pour la premi\u00e8re fois une recommandation applicable \u00e0 l\u2019\u00e9chelle mondiale concernant la prise en……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":560806,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Recommandation g\u00e9n\u00e9rale, autorisation de Swissmedic et limitation SL","footnotes":""},"category":[11549,11378,11404,11527,11531,11315,11410,11464,11482],"tags":[12410,95545,80779,17458,95535,95546],"powerkit_post_featured":[],"class_list":["post-560805","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-cardiologie","category-endocrinologie-et-diabetologie","category-etudes","category-formation-continue","category-medecine-interne-generale","category-nutrition-fr","category-pharmacologie-et-toxicologie","category-prevention-et-soins-de-sante","tag-obesite","tag-recommandation-generale","tag-select-fr","tag-semaglutid-fr","tag-sommet","tag-step-hfpef","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-20 04:44:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":560808,"slug":"linee-guida-delloms-sul-glp-1-nellobesita","post_title":"Linee guida dell\u2019OMS sul GLP-1 nell\u2019obesit\u00e0","href":"https:\/\/medizinonline.com\/it\/linee-guida-delloms-sul-glp-1-nellobesita\/"},"pt_PT":{"locale":"pt_PT","id":560811,"slug":"orientacao-da-oms-sobre-o-glp-1-na-obesidade","post_title":"Orienta\u00e7\u00e3o da OMS sobre o GLP-1 na obesidade","href":"https:\/\/medizinonline.com\/pt-pt\/orientacao-da-oms-sobre-o-glp-1-na-obesidade\/"},"es_ES":{"locale":"es_ES","id":560814,"slug":"directrices-de-la-oms-sobre-el-glp-1-en-la-obesidad","post_title":"Directrices de la OMS sobre el GLP-1 en la obesidad","href":"https:\/\/medizinonline.com\/es\/directrices-de-la-oms-sobre-el-glp-1-en-la-obesidad\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/560805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=560805"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/560805\/revisions"}],"predecessor-version":[{"id":560807,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/560805\/revisions\/560807"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/560806"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=560805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=560805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=560805"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=560805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}